{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:51:14Z","timestamp":1793389874106,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-025-01052-8","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:38:09Z","timestamp":1767843489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Osmotic nephropathy as a potentially underrecognized cause of acute kidney injury during SGLT2 inhibitor therapy: a case report and literature review"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8000-9955","authenticated-orcid":false,"given":"Akane","family":"Murata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mako","family":"Takayoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Teragaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachio","family":"Iwanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Takeoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"1","key":"1052_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12325-021-01994-2","volume":"39","author":"CW Mende","year":"2022","unstructured":"Mende CW. Chronic kidney disease and SGLT2 inhibitors: a review of the evolving treatment landscape. Adv Ther. 2022;39(1):148\u201364.","journal-title":"Adv Ther"},{"issue":"3","key":"1052_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1053\/j.ajkd.2007.10.044","volume":"51","author":"M Dickenmann","year":"2008","unstructured":"Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis. 2008;51(3):491\u2013503.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1052_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.kint.2022.01.025","volume":"102","author":"G Jagannathan","year":"2022","unstructured":"Jagannathan G, Finkielstein VA, Markowitz GS, Kudose S. Armanni\u2013Ebstein lesion in a diabetic patient with acute tubular injury. Kidney Int. 2022;102(1):213.","journal-title":"Kidney Int"},{"issue":"6","key":"1052_CR4","first-page":"1035","volume":"33","author":"S Ritchie","year":"1957","unstructured":"Ritchie S, Waugh D. The pathology of Armanni\u2013Ebstein diabetic nephropathy. Am J Pathol. 1957;33(6):1035\u201357.","journal-title":"Am J Pathol"},{"key":"1052_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1017\/9781316613986","volume-title":"Silva\u2019s diagnostic renal pathology","author":"XJ Zhou","year":"2017","unstructured":"Zhou XJ, Laszik Z, Nadasdy T, D\u2019Agati VD. Silva\u2019s diagnostic renal pathology. Cambridge: Cambridge University Press; 2017. p. 450\u20135."},{"issue":"2","key":"1052_CR6","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1053\/j.ajkd.2016.12.003","volume":"69","author":"AB Fogo","year":"2017","unstructured":"Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD atlas of renal pathology: osmotic tubular injury. Am J Kidney Dis. 2017;69(2):e11\u20132.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"1052_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1053\/j.ajkd.2023.09.017","volume":"83","author":"N Krishnan","year":"2024","unstructured":"Krishnan N, Moledina DG, Perazella MA. Toxic nephropathies of the tubulointerstitium: core curriculum 2024. Am J Kidney Dis. 2024;83(5):659\u201376.","journal-title":"Am J Kidney Dis"},{"key":"1052_CR8","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/imj.16540","volume":"54","author":"A Muthya","year":"2024","unstructured":"Muthya A, Ekinci EI, Lecamwasam A. What is the spectrum of kidney pathology associated with COVID-19? Intern Med J. 2024;54:1935\u201343.","journal-title":"Intern Med J"},{"issue":"3","key":"1052_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.34067\/KID.0007882021","volume":"3","author":"MA Perazella","year":"2022","unstructured":"Perazella MA, Juncos LA. Drug-induced osmotic nephropathy: Add SGLT2-inhibitors to the list? Kidney360. 2022;3(3):550\u20133.","journal-title":"Kidney360"},{"issue":"1","key":"1052_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1053\/j.ajkd.2020.01.015","volume":"76","author":"G Phadke","year":"2020","unstructured":"Phadke G, Kaushal A, Tolan DR, Hahn K, Jensen T, Bjornstad P, et al. Osmotic nephrosis and acute kidney injury associated with SGLT2 inhibitor use: a case report. Am J Kidney Dis. 2020;76(1):144\u20137.","journal-title":"Am J Kidney Dis"},{"key":"1052_CR11","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.kint.2024.10.035","volume":"107","author":"Y Kawata","year":"2025","unstructured":"Kawata Y, Araki M, Onodera Y, Ogawa Y, Yanai M. Osmotic nephropathy induced by SGLT2 inhibitor overdose. Kidney Int. 2025;107:1116.","journal-title":"Kidney Int"},{"issue":"3","key":"1052_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.47102\/annals-acadmedsg.2020526","volume":"50","author":"CSM Sia","year":"2021","unstructured":"Sia CSM, Leong LCY, Wong ETY, Goh GH, Leo CCH. Empagliflozin-induced severe osmotic nephrosis and acute renal injury in advanced chronic kidney disease. Ann Acad Med Singap. 2021;50(3):255\u20137.","journal-title":"Ann Acad Med Singap"},{"issue":"4","key":"1052_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s13730-021-00609-7","volume":"10","author":"S Watanabe","year":"2021","unstructured":"Watanabe S, Sawa N, Mizuno H, Yamanouchi M, Suwabe T, Hoshino J, et al. Development of osmotic vacuolization of proximal tubular epithelial cells following treatment with sodium-glucose transport protein 2 inhibitors in type II diabetes mellitus patients-3 case reports. CEN Case Rep. 2021;10(4):563\u20139.","journal-title":"CEN Case Rep"},{"key":"1052_CR14","first-page":"395","volume":"11","author":"BF Trump","year":"1962","unstructured":"Trump BF, Janigan DT. The pathogenesis of cytologic vacuolization in sucrose nephrosis. An electron microscopic and histochemical study. Lab Invest. 1962;11:395\u2013411.","journal-title":"Lab Invest"},{"issue":"3","key":"1052_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000179925","volume":"8","author":"SL Schwartz","year":"1971","unstructured":"Schwartz SL, Johnson CB. Pinocytosis as the cause of sucrose nephrosis. Nephron. 1971;8(3):246\u201354.","journal-title":"Nephron"},{"key":"1052_CR16","first-page":"421","volume":"11","author":"AB Maunsbach","year":"1962","unstructured":"Maunsbach AB, Madden SC, Latta H. Light and electron microscopic changes in proximal tubules of rats after administration of glucose, mannitol, sucrose, or dextran. Lab Invest. 1962;11:421\u201332.","journal-title":"Lab Invest"},{"issue":"3","key":"1052_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.semarthrit.2004.06.003","volume":"34","author":"H Orbach","year":"2004","unstructured":"Orbach H, Tishler M, Shoenfeld Y. Intravenous immunoglobulin and the kidney\u2014a two-edged sword. Semin Arthritis Rheum. 2004;34(3):593\u2013601.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"1052_CR18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/toxsci\/kfy151","volume":"165","author":"K Matsushita","year":"2018","unstructured":"Matsushita K, Takasu S, Kuroda K, Ishii Y, Kijima A, Ogawa K, et al. Mechanisms underlying exacerbation of osmotic nephrosis caused by pre-existing kidney injury. Toxicol Sci. 2018;165(2):420\u201330.","journal-title":"Toxicol Sci"},{"key":"1052_CR19","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.34067\/KID.0002772021","volume":"2","author":"EM Wright","year":"2021","unstructured":"Wright EM. SGLT2 inhibitors\u202f: physiology and pharmacology. Kidney 360. 2021;2:2027\u201337.","journal-title":"Kidney 360"},{"issue":"8","key":"1052_CR20","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1111\/dom.13754","volume":"21","author":"RE Gilbert","year":"2019","unstructured":"Gilbert RE, Thorpe KE. Acute kidney injury with sodium-glucose co-transporter-2 inhibitors: a meta-analysis of cardiovascular outcome trials. Diabetes Obes Metab. 2019;21(8):1996\u20132000.","journal-title":"Diabetes Obes Metab"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-01052-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-025-01052-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-01052-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:38:31Z","timestamp":1767843511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-025-01052-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1052"],"URL":"https:\/\/doi.org\/10.1007\/s13730-025-01052-8","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient for the publication of his clinical data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"16"}}